TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Pharma Production i Stockholm AB
Closing information (x1000 EUR)
Closing information | 2024/06 | 2023/06 | 2022/06 |
Turnover |
1,090
|
1,014
|
1,142 |
Financial expenses |
0
![]() |
0
![]() |
0 |
Earnings before taxes |
413
|
396
|
523 |
EBITDA |
407
|
398
|
525 |
Total assets |
567
|
362
|
418 |
Current assets |
558
|
350
|
409 |
Current liabilities |
307
|
74
|
95 |
Equity capital |
260
|
288
|
323 |
- share capital |
9
|
8
|
9 |
Employees (average) |
0
![]() |
0
![]() |
0 |
Financial ratios
Fiscal year | 2024/06 | 2023/06 | 2022/06 |
Solvency |
45.9%
|
79.6%
|
77.3% |
Turnover per employee | |||
Profit as a percentage of turnover |
37.9%
|
39.1%
|
45.8% |
Return on assets (ROA) |
72.8%
|
109.4%
|
125.1% |
Current ratio |
181.8%
|
473.0%
|
430.5% |
Return on equity (ROE) |
158.8%
|
137.5%
|
161.9% |
Change turnover |
37
|
-20
|
-14 |
Change turnover % |
4%
|
-2%
|
-1% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2024/06 | 2023/06 | 2022/06 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.